Celcuity
Dr. Lim is an Assistant Professor of Breast Medical Oncology in the Section of Translational Breast Cancer Research at the University of Texas MD Anderson Cancer Center. She is a translational investigator researching novel therapeutic strategies to halt or treat aggressive breast cancer by apoptosis (effective cancer cell-killing) induction. She studies new ways of delivering these novel agents and determining target populations using new diagnostic methods such as liquid biopsy and single-cell genomics. Dr. Lim actively runs five active investigator-initiated clinical trials and associated biomarker studies.
This person is not in the org chart
This person is not in any offices
Celcuity
Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages the CELsignia CDx platform.